Interview: Pfizer's Smith On Building A Gene Therapy Business

Pfizer entered the gene therapy space in 2014 and now has three programs in the clinic. Robert Smith, head of Pfizer’s gene therapy unit, spoke to Scrip about the company strategy, as well as the regulatory and reimbursement landscape.

Smith_Bob
Robert Smith heads Pfizer's gene therapy unit • Source: Pfizer

More from Gene Therapies

More from Advanced Therapies